Top Story

8:22 am

Royal Dutch Shell mega-merger with BG gets EU green light

Royal Dutch Shell has obtained regulatory approval from the European Commission to buy BG Group, clearing another anti-trust hurdle to completing the near £50bn acquisition. 


Breaking News

Wednesday, September 02, 8:42 am

Ambarella tumbles despite strong Q2 results

Ambarella (NASDAQ:AMBA) retreated in early trading even as the video-compression chipmaker reported higher-than-expected results in its fiscal second quarter. Shares were down 10% as of 8:32 a.m. ...

International

8:22 am

EU officials give Shell’s BG bid the nod

The mega-merger was always going to be scrutinised closely by regulators

Articles

  • Relief rally is on the cards after Chinese markets calm down

    US stocks are set to claw back some of yesterday's eye-watering losses - except, maybe, oil related stocks, as the oil price's rally seems to have hit the buffers.

  • Mandalay Resources' acquisition drive pays dividends

    The miner seems to have weathered the storm in the sector better than most juniors. 

  • US and global shares tanking as China worries worsen

    Just when you thought things might ease, US shares crashed out again on Tuesday, with the Dow Jones dropping (INDEXDJX:.DJI) 422 points to 16,105 at 3:30 p.m. as traders around the globe took flight after weak China data. The tech heavy Nasdaq (INDEXNASDAQ:.IXIC) dropped 122 points to 4,654, while the broader based S&P 500 (INDEXSP:.INX) eased 52 points to 1,920.

  • TSX sinks as downbeat China data spurs global selloff; Penn West, Pengrowth drop

    Canadian shares sank as downbeat economic from China, the nation’s second-largest trading partner, sparked global selloff and nudged down energy prices. The benchmark Standard & Poor’s/TSX Composite Index (TSE:OSPTX) tumbled 2.2% to 13,559.17 at 12:18 p.m. in Toronto. Ten shares declined for every issue that advanced as all of the 10 groups were in the negative territory.

  • Valeant Pharmaceuticals licenses psoriasis drug from AstraZeneca

    After Amgen, the originator of the skin condition treatment, abandoned brodalumab, Astra has called on the Canadian dermatology specialist to develop the drug.

  • Falcon chief hails Aussie drill result as 'excellent start'

    Falcon Oil & Gas (LON:FOG, CVE:FO) chief Philip O'Quigley hailed as an “excellent start” the drill results from its first well in Australia’s Beetaloo Basin. Kalala S-1 intercepted more than 500 metres of shale gas with a net pay (the potentially economic portion) of 150 metres.


Archived Top Stories ►
  • Tango Mining boss delighted with BK11 diamond estimate

    Terry Tucker, chief executive of TSX Venture-listed Tango Mining (CVE:TGV) says the updated resource estimate from its BK11 Botswana...
    View full size
  • Anglo Pacific “has turned a corner”, says CEO Treger Share

    Julian Treger, chief executive of Anglo Pacific Group (LON:APF) (TSX:APY), says the company has turned a corner after managing to weather a...
    View full size
  • Aureus Mining CFO: Plenty more to come after New Liberty gold pour

    Paul Thomson, chief financial officer of Aureus Mining (LON:AUE) (TSE:AUE), says there’s plenty more to come from the company after it...
    View full size
  • Orosur Mining taking decisive steps to tackle gold price

    Ignacio Salazar, chief executive & director of Orosur Mining (LON:OMI) (TSE:OMI), explains the steps being taken by the Latin American miner...
    View full size
  • China yuan devaluation may be good for miners says IG Group’s Mahony

    Joshua Mahony, market analyst at IG Group, reckons the mining sector could be a long-term beneficiary of a weaker yuan. China’s devaluation...
    View full size
  • MOKO Social Media COO on niche audience opportunities

    The chief operating officer of MOKO Social Media (NASDAQ:MOKO), Shripal Shah, discusses the company’s unique approach when it comes to...
    View full size
  • Midatech Pharma chief: Ophthotech deal “significant piece of business”

    The chief executive of Midetech Pharma (LON:MTPH), Jim Phillips, provides more detail on the firm’s collaboration with US–listed Ophthotech...
    View full size
  • Caledonia Mining CFO eyes extra ounces from Blanket gold mine

    Caledonia Mining’s (LON:CMCL, TSE:CAL) finance chief, Mark Learmonth, says work on the firm’s Blanket mine in Zimbabwe mean more ounces of...
    View full size
  • MagneGas boss eyes revenue uplift from US metal cutting market

    The chief executive of Florida-based MagneGas (NASDAQ:MNGA), Ermanno Santilli, potential revenue from the metal cutting market in the United...
    View full size
  • Asiamet Resources chief on refreshed strategy

    Tony Manini, the chief executive of Asiamet Resources (LON:ARS) (CVE:ARS), formerly Kalimantan Gold, explains the new strategy and forward...
    View full size
  • VolitionRx chief says key milestones are within reach

    The chief executive of cancer diagnostics specialist Volition RX (NYSE:VNRX), Cameron Reynolds, says investors can expect the company to...
    View full size
  • Westhouse analyst Henderson on US vs OPEC oil dynamics

    Mark Henderson, director of oil & gas at Westhouse Securities, discusses the outlook for oil prices and the ongoing price war between the US...
    View full size